Wanbang Pharmaceuticals: Net profit loss of 261.8k yuan in the first quarter of 2026

Wanbang Pharmaceutical announces that revenue for the first quarter of 2026 was 30.5413 million yuan, a year-on-year decrease of 57.02%; net loss was 261.8k yuan, compared to a net profit of 11.8493 million yuan in the same period last year.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin